Grant of Options under CVS Group plc

CVS Group plc
24 November 2023
 

 

 

24 November 2023

CVS Group plc

("CVS" or the "Company")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2023/2024 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors and the person closely associated (PCA) named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman                                                      550 SAYE scheme options

Robin Alfonso                                                          550 SAYE scheme options

Ben Jacklin                                                               517 SAYE scheme options

Katherine Jacklin (PCA to Ben Jacklin)  550 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,146 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2023, being the invitation date.

 

In response to accepted invitations, a total of 558,994 SAYE Scheme options over Ordinary Shares were granted on 24 November 2023, equating to 0.79% of the current issued ordinary share capital.  Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2027.  

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 



CVS Group plc                                                                                                    via Camarco

Richard Fairman, CEO

Scott Morrison Group Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)                                                 +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker)                                                                                   +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                         +44 (0)7733 124 226

Ginny Pulbrook                                                                                                     +44 (0)7961 315 138

   

 

 

 



 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p


550

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price


e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p


550

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price


e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Deputy CEO

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p

 

517

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price


e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Katherine Jacklin

2

Reason for the notification

a)

Position/status

PCA to Deputy CEO Ben Jacklin

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,146p

 

550

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price


e)

Date of the transaction

24 November 2023

f)

Place of the transaction

Off market


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings